Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Issue: Product safety
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 20194 results available
- November 20191 results available
- October 20192 results available
- September 20193 results available
- July 20193 results available
- June 20193 results available
- May 20194 results available
- April 20194 results available
- March 20194 results available
- February 20192 results available
- January 20192 results available
Displaying 16 - 30 of 32 items.
Health Canada warns Canadians of potential cancer risk associated with gentian violet
AlertInformation update | 2019-06-12
Health products manufactured by Konsar Future Nutrition Inc. may pose serious health risks
AlertInformation update | 2019-05-29
Health Canada suspends Allergan's licences for its Biocell breast implants after safety review concludes an increased risk of cancer
AlertInformation update | 2019-05-28
Health Canada is advising Canadians about the potential health risks associated with unauthorized cell therapy treatments such as stem cell therapy
AlertInformation update | 2019-05-15
Testing finds pharmaceutical ingredients in unauthorized health products seized from Sunrise Lee Chinese Herbs Centre in Calgary, Alberta
AlertInformation update | 2019-05-08
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd.
AlertInformation update | 2019-04-12
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12